BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Caplin Point Laboratories Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524742
ISIN Demat
INE475E01026
Book Value (Rs)
269.7614245
NSE Symbol
CAPLIPOINT
Divident Yield %
0.17
Market Cap
(Rs In Cr.)
17,967
P/E (TTM)
45.31
EPS (TTM)
52.17
Face Value
(Rs)
2
Back
Caplin Point Laboratories consolidated net profit rises 17.93% in the December 2025 quarter
05-Feb-26   Hrs IST

Net profit of Caplin Point Laboratories rose 17.93% to Rs 163.88 crore in the quarter ended December 2025 as against Rs 138.96 crore during the previous quarter ended December 2024. Sales rose 10.10% to Rs 542.77 crore in the quarter ended December 2025 as against Rs 492.96 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales542.77492.96 10
OPM %34.9432.92 -
PBDT223.17193.46 15
PBT203.89177.26 15
NP163.88138.96 18

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)